| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
1,770,000,000 |
| Market
Cap: |
282.53(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$132.51 - $182.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 560 |
| Guru Rank Value : 3 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
459,004 |
461,916 |
540,416 |
1,579,317 |
| Total Sell Value |
$81,195,771 |
$81,646,316 |
$93,320,391 |
$252,708,726 |
| Total People Sold |
9 |
9 |
9 |
14 |
| Total Sell Transactions |
10 |
11 |
13 |
37 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Michael Robert A. |
Vice Chairman |
• – – |
2022-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
77,391 |
115,268 |
|
- |
|
| Gosebruch Henry O |
EVP, Chief Strategy Officer |
• – – |
2022-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
68,068 |
86,779 |
|
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2022-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
232,078 |
608,675 |
|
- |
|
| Schumacher Laura J |
Vice Chairman |
• – – |
2022-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
91,394 |
288,492 |
|
- |
|
| Hudson Thomas J |
SVP, R&D and CSO |
• – – |
2022-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
30,264 |
59,636 |
|
- |
|
| Strom Carrie C |
SVP & Pres Global Allerg Aesth |
• – – |
2022-02-07 |
4 |
S |
$141.17 |
$338,243 |
D/D |
(2,396) |
42,499 |
|
2% |
|
| Strom Carrie C |
SVP & Pres Global Allerg Aesth |
• – – |
2022-02-07 |
4 |
A |
$47.27 |
$197,778 |
D/D |
4,184 |
44,895 |
|
- |
|
| Strom Carrie C |
SVP & Pres Global Allerg Aesth |
• – – |
2021-12-31 |
4 |
D |
$135.93 |
$1,404,972 |
D/D |
(10,336) |
40,711 |
|
- |
|
| Severino Michael |
Vice Chairman |
• – – |
2021-12-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
583 |
103,252 |
|
- |
|
| Schumacher Laura J |
Vice Chairman |
• – – |
2021-12-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,905 |
197,098 |
|
- |
|
| Durkin Brian L |
VP, Controller |
• – – |
2021-12-20 |
4 |
S |
$128.51 |
$1,515,133 |
D/D |
(11,790) |
16,505 |
|
-14% |
|
| Durkin Brian L |
VP, Controller |
• – – |
2021-12-20 |
4 |
OE |
$61.36 |
$440,565 |
D/D |
7,180 |
28,295 |
|
- |
|
| Schumacher Laura J |
Vice Chairman |
• – – |
2021-12-17 |
4 |
S |
$130.23 |
$23,660,678 |
D/D |
(181,670) |
213,003 |
|
-13% |
|
| Schumacher Laura J |
Vice Chairman |
• – – |
2021-12-17 |
4 |
OE |
$54.86 |
$10,381,361 |
D/D |
181,670 |
394,673 |
|
- |
|
| Stewart Jeffrey Ryan |
EVP, Chief Commercial Officer |
• – – |
2021-12-15 |
4 |
S |
$128.00 |
$275,456 |
D/D |
(2,152) |
47,104 |
|
-21% |
|
| Sorg Elaine K. |
SVP, US Commercial Operations |
• – – |
2021-12-13 |
4 |
S |
$125.85 |
$812,739 |
D/D |
(6,458) |
0 |
|
-24% |
|
| Sorg Elaine K. |
SVP, US Commercial Operations |
• – – |
2021-12-10 |
4 |
D |
$124.15 |
$637,759 |
D/D |
(5,137) |
6,458 |
|
- |
|
| Stewart Jeffrey Ryan |
EVP, Chief Commercial Officer |
• – – |
2021-12-10 |
4 |
D |
$124.15 |
$212,669 |
D/D |
(1,713) |
49,256 |
|
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2021-12-09 |
4 |
S |
$122.80 |
$21,453,641 |
D/D |
(174,100) |
376,597 |
|
-28% |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2021-12-09 |
4 |
OE |
$61.36 |
$10,682,776 |
D/D |
174,100 |
550,697 |
|
- |
|
| Richmond Timothy J. |
EVP, Chief HR Officer |
• – – |
2021-12-06 |
4 |
S |
$120.00 |
$6,042,000 |
D/D |
(50,350) |
0 |
|
-31% |
|
| Richmond Timothy J. |
EVP, Chief HR Officer |
• – – |
2021-12-06 |
4 |
OE |
$58.88 |
$2,964,608 |
D/D |
50,350 |
50,350 |
|
- |
|
| Austin Roxanne S |
Director |
– • – |
2021-11-03 |
4 |
S |
$117.23 |
$2,344,600 |
D/D |
(20,000) |
49,284 |
|
-35% |
|
| Austin Roxanne S |
Director |
– • – |
2021-11-02 |
4 |
S |
$115.23 |
$6,033,384 |
D/D |
(51,844) |
69,284 |
|
-34% |
|
| Gosebruch Henry O |
EVP, Chief Strategy Officer |
• – – |
2021-09-07 |
4 |
GA |
$0.00 |
$0 |
I/I |
30,000 |
78,500 |
|
- |
|
641 Records found
|
|
Page 8 of 26 |
|
|
7.67 (4.58%) 
